/wuxi-xdc-congratulates-lanova-medicines-and-turning-point-therapeutics-enter-into-licensing-agreement-for-lm-302-antibody-drug-conjugate-program/ 提供端到端一站式解决方案 Thu, 26 May 2022 03:01:55 +0000 hourly 1